OpenLegislation

Regulation 2 Amendment of the Misuse of Drugs Regulations (Northern Ireland) 2002I1

Northern Ireland

(1)

The Misuse of Drugs Regulations (Northern Ireland) 2002f1 are amended as follows.

(2)

In paragraph 1(a) of Schedule 1 (Controlled Drugs subject to the requirements of Regulations 14, 15, 16, 18, 19, 20, 23, 26 and 27)—

(a)

after “Bromazolam (8-bromo-1-methyl-6-phenyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepine)” insert “Brorphine”;

(b)

after “Bufotenine” insert “Butonitazene”;

(c)

after “Clonazolam (6-(2-Chlorophenyl)-1-methyl-8-nitro-4H-[1,2,4]triazolo[4,3-a][1,4] benzodiazepine)” insert “Clonitazene”;

(d)

after “Concentrate of poppy-straw” insert “Cumyl-PeGaClone”;

(e)

after “3-Dimethylheptyl-11-hydroxyhexahydrocannabinol” insert—

“Diphenidine

Ephenidine

Ethyleneoxynitazene”;

(f)

after “Etizolam” insert—

“Etodesnitazene (etazene)

Etonitazene”;

(g)

after “Flubromazolam (8-Bromo-6-(2-fluorophenyl)-1-methyl-4H-[1,2,4]triazolo[4,3-a][1,4] benzodiazepine)” insert “Flunitazene”;

(h)

after “Isopropylphenidate (IPP or IPPD)” insert “Isotonitazene”;

(i)

after “Methcathinone” insert “Methoxyphenidine”;

(j)

after “Metizolam (4-(2-Chlorophenyl)-2-ethyl-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4] diazepine)” insert—

“Metodesnitazene (metazene)

Metonitazene”;

(k)

after “Propylphenidate” insert “Protonitazene”;

(l)

after “1-Cyclohexyl-4-(1,2-diphenylethyl)piperazine (MT-45)” insert—

“N-Desethyl etonitazene

N-Desethylisotonitazene

N-Desethyl protonitazene”;

(m)

after “4-Methyl-5-(4-methylphenyl)-4,5-dihydrooxazol-2-amine (4,4’-DMAR)” insert—

“N-Piperidinyl-etonitazene (etonitazepipne)

N-Pyrrolidino-etonitazene (etoniazepyne)

N-Pyrrolidino protonitazene”.

(3)

In paragraph 1 of Schedule 2 (Controlled Drugs subject to the requirements of regulations 14, 15, 16, 16A, 18, 19, 20, 21, 23, 26 and 27) omit “Clonitazene” and “Etonitazene”.

(4)

In paragraph 1 of Part 1 of Schedule 4 (which specifies controlled drugs subject to the requirements of regulations 22, 23, 26 and 27) after “Pyrovalerone” insert “Remimazolam”.

Annotations

Commencement

I1

Reg. 2 in operation at 27.3.2024, see reg. 1(1)

Footnotes

f1

S.R. 2002 No. 1, amended by SR 2015 No. 227 and 2018 No. 4. There are other amending instruments but none are relevant.